European Circular Bioeconomy Fund (ECBF) hat dies direkt geteilt
🎉 Congratulations to Nuritas on securing an impressive $42 million in their #SeriesC funding round! We are thrilled to continue our support for this groundbreaking company as they revolutionize ingredient discovery through AI-powered peptide innovation. Nuritas is truly setting the standard for the future of health and nutrition. 🌿 A warm welcome to the new investors, M&G Investments and McWin Capital Partners. Your expertise will undoubtedly accelerate Nuritas' global expansion and impact. Nuritas' achievements speak volumes: 🧬 Launching innovative products like PeptiStrong™ and PeptiYouth™ 🧬 Forming strategic partnerships with industry giants 🧬 Planning to introduce three new clinically validated peptide ingredients in 2025. We firmly believe in Nuritas' potential to improve billions of lives through their AI-driven approach to unlocking nature's hidden health benefits. Their Magnifier NπΦ platform is a game-changer, identifying peptides 10-50 times faster than traditional methods. We are excited to be part of your journey as Nuritas continues to push the boundaries of biotechnology and create a healthier future for all. 💚 Thanks to Marie Asano for her effort, supporting the team with this amazing Series C round. 👉 Read the press release here: https://bit.ly/3BEc1Hp #Nuritas #BiotechInnovation #AIinHealthcare #SustainableHealth